Finding blood biomarkers to inform local inflammation in coronary artery disease

As an anti-inflammatory drug has been recently approved to prevent heart attacks in heart disease patients, specific blood tests are needed to guide the application of such drugs. There is currently no blood test to identify patients who may benefit from this drug. This project aims to evaluate the accuracy of a current clinical blood test and find blood tests that more accurately reveal local inflammation in the heart. By studying the inflammation pathways in the heart and its associated markers in the blood, we hope to identify blood tests that could accurately guide clinical decision-making. Through this project, the partner organization will gain new opportunities to collaborate with another research centre, and gain visibility in academic and professional conferences, which could attract further collaborations.

Faculty Supervisor:

Ying Wang

Student:

Partner:

PROOF Centre of Excellence

Discipline:

Life Sciences

Sector:

Health and Related Sciences & Technology; Professional, scientific and technical services

University:

The University of British Columbia

Program: